Yu‐Wen Cheng

966 citations
50 papers · 677 indexed · h-index 13
Topics
Cerebrovascular and genetic disorders (17 papers)Moyamoya disease diagnosis and treatment (13 papers)Intracerebral and Subarachnoid Hemorrhage Research (6 papers)
Partner nations
TaiwanGermanyChina

In The Last Decade

Yu‐Wen Cheng

45 papers receiving 651 citations

Peers

Yu‐Wen Cheng
Comparison fields: 5 of 106
  • Dermatology 151
  • Molecular Biology 149
  • Neurology 114
  • Psychiatry and Mental health 99
  • Epidemiology 86
Replace Ali Amini Harandi with:
Ali Amini Harandi Iran
Caterina Lonati Italy
Mona Shahriari United States
J Schnitker Germany
Ilya Mukovozov Canada
Hiroyuki Kobayashi Japan
Lev Pavlovsky Israel
Hana Yoon South Korea
Yōko Takahashi Japan
Yu‐Wen Cheng relative to Ali Amini Harandi Iran Ali Amini Harandi's profile →
Citations per field
00.5×3.0×
Ali Amini Harandi · 1×
Citations per year

Countries citing papers authored by Yu‐Wen Cheng

Since Specialization
Citations

This map shows the geographic impact of Yu‐Wen Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu‐Wen Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu‐Wen Cheng more than expected).

Fields of papers citing papers by Yu‐Wen Cheng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yu‐Wen Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu‐Wen Cheng. The network helps show where Yu‐Wen Cheng may publish in the future.

Co-authorship network of co-authors of Yu‐Wen Cheng

This figure shows the co-authorship network connecting the top 25 collaborators of Yu‐Wen Cheng. A scholar is included among the top collaborators of Yu‐Wen Cheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yu‐Wen Cheng. Yu‐Wen Cheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 2
3 1
4 4
5 6
6 2
7 9
8 6
9 32
10 6
11 107
12 10
13
HIV-associated parkinsonism reversed with antiretroviral therapy
4
14 8
15 3
16 55
17 3
18 48
19 17
20 4

About Yu‐Wen Cheng

Yu‐Wen Cheng is a scholar working on Neurology, Rheumatology and Dermatology, having authored 50 papers that have together received 677 indexed citations. Recurring topics across this work include Cerebrovascular and genetic disorders (17 papers), Moyamoya disease diagnosis and treatment (13 papers) and Intracerebral and Subarachnoid Hemorrhage Research (6 papers). The work is most often cited by research in Dermatology (151 citations), Neurology (65 citations) and Neurology (114 citations). Yu‐Wen Cheng has collaborated with scholars based in Taiwan, Germany and China. Frequent co-authors include Ta‐Fu Chen, Ming‐Jang Chiu, Jaw‐Jou Kang, Ching-Hao Li, WenChieh Chen, Sung‐Chun Tang, Chih‐Hao Chen, Ya‐Fang Chen, Jiann‐Shing Jeng and Po-Lin Liao. Their work appears in journals such as Journal of Biological Chemistry, PLoS ONE and Neurology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026